September 24, 2017 9:35 PM ET


Company Overview of Novagali Pharma S.A.

Company Overview

Novagali Pharma S.A. engages in the development and commercialization of ophthalmic products for various segments of the eye. Its product pipeline includes a range of products that address the diseases encountered at various segment levels of the eye, such as dry eye, allergy, glaucoma, and retinopathies. The company offers Cationorm, a product that treats the symptoms of dry eye; Cyclokat, a phase III product candidate for the treatment of moderate to severe dry eye; and Vekacia, a phase III product candidate for the treatment of vernal keratoconjunctivitis. It also provides Catioprost, a phase II product candidate for the treatment of glaucoma; and Cortiject, a phase I product candidate fo...

1 Rue Pierre Fontaine

Genavenir IV Cedex

Evry,  91058


Founded in 2000

42 Employees


33 1 69 87 40 20


33 1 69 87 40 30

Key Executives for Novagali Pharma S.A.

Chairman of Management Board, CEO, President and Director of Business Development
Age: 55
Co-Founder and Member of Scientific Advisory Board
CAO, CFO, VP of Administrative & Financial Mgmt & Member of Mgmt Board
Age: 59
Director of Communication & Human Resources
Age: 60
Executive Officer
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
4P Pharma Europe
A.T.O. ZIZINE S.A.S Europe
Advicenne Pharma Europe
Aerocid Europe
AG Pharma Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Tax Management Inc United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Novagali Pharma S.A., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at